InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference

Core Viewpoint - InspireMD, Inc. is set to participate in a fireside discussion at the Piper Sandler 37th Annual Healthcare Conference on December 3rd, 2025, highlighting its focus on carotid stenting technology aimed at stroke prevention [1]. Company Overview - InspireMD, Inc. develops the CGuard® Prime carotid stent system, utilizing proprietary MicroNet™ mesh technology to establish its products as the industry standard for carotid stenting [2]. - The company aims to deliver exceptional acute results and long-term outcomes that are stroke-free, emphasizing its commitment to innovation in the healthcare sector [2]. - InspireMD's common stock is traded on Nasdaq under the ticker symbol NSPR, and the company actively shares important investor information on its website [2].